Rachel Brog Garlick

Rachel Brog Garlick is currently the Co-Founder at Eris Biotech. Prior to that, Rachel worked as a Senior Scientist at Thunder Biotech, where Rachel led process development for genetic engineering and immunotherapy treatments. Rachel was also a PHD Candidate at Geisel School of Medicine, where Rachel developed novel CAR T cells. Additionally, Rachel has experience as a Senior Associate at Orange Grove Bio, a Research Assistant at Brigham Young University, and a Patient Service Representative at Intermountain Healthcare. Rachel holds a Ph.D. in Microbiology and Immunology from Geisel School of Medicine and a Bachelor of Science in Molecular Biology from Brigham Young University. Rachel also completed a course for credit at The Tuck School of Business at Dartmouth.